Package 50090-7422-1

{"route": ["ORAL"], "spl_id": "09fd6ebb-17e7-4c6f-998d-289eefc5ba27", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["bb63261f-ad18-4885-9ed7-e7dfde33e171"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-0)", "package_ndc": "50090-7422-0", "marketing_start_date": "20241028"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-1)", "package_ndc": "50090-7422-1", "marketing_start_date": "20241028"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-2)", "package_ndc": "50090-7422-2", "marketing_start_date": "20241028"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-3)", "package_ndc": "50090-7422-3", "marketing_start_date": "20241028"}], "brand_name": "Bupropion hydrochloride", "product_id": "50090-7422_09fd6ebb-17e7-4c6f-998d-289eefc5ba27", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-7422", "generic_name": "Bupropion hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA216800", "marketing_category": "ANDA", "marketing_start_date": "20230531", "listing_expiration_date": "20261231"}